Are We Going to See a Step Function Change in Human Longevity?

In this episode, David A. Sinclair, Ph.D., a Professor in the Department of Genetics at Harvard Medical School and co-Director of the Paul F. Glenn Center for the Biological Mechanisms of Aging, provides insight into why we age and how to slow its effects based on his remarkable work on the role of sirtuins and NAD in health and diseases. He also presents the case that stabilizing the epigenetic landscape may be the linchpin in counteracting aging and disease. 

We discuss:

• How and why David moved from Australia to Leonard Guarente’s lab at MIT [7:30];
• Sirtuins and aging [15:00];
• A series of experiments elucidating the mechanisms of sirtuins [20:45];
• How are sirtuins activated? [25:30];
• NAD and sirtuin activation [31:00];
• Nicotinamide, sirtuin inhibition, andPNC1 [39:00];
• Resveratrol [43:00];
• The NIH/ITP studies on resveratrol [55:45];
• Does David take any compounds for longevity? [1:00:15];
• NAD precursors (NR, NMN) and pterostilbene [1:02:45];
• Female fertility and NAD precursors [1:14:45];
• A unifying theory of aging [1:20:30];
• Waddington’s epigenetic landscape [1:23:00];
• If David had unlimited resources, what is the experiment he would do? [1:28:25];
• Testing combinations to extend lifespan [1:31:30];
• What made David aware of his mortality at such a young age? [01:33:45];
• What is David’s book going to cover? [01:37:15]; and
• More.

Learn more at www.PeterAttiaMD.com

Connect with Peter on Facebook | Twitter | Instagram.